Defense Spending Is Accelerating the Commercialization of Quantum Computing

(NasdaqGM:VWAV),(NYSE:IONQ),(NASDAQ:KTOS),(NASDAQ:RGTI),(NYSE MKT:UAVS), NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Market News Updates News Commentary – Quantum computing is moving from the lab into real-world military use, and defense organizations are paying close attention. Unlike traditional computing, quantum systems can process extraordinarily complex variables at once, which is highly relevant for modern military operations. Applications […]

Sify reports Consolidated Financial Results for Q3 FY 2025-26

Sify reports Consolidated Financial Results for Q3 FY 2025-26 GlobeNewswire January 12, 2026 Revenues of INR 11596 Million. EBITDA of INR 2470 Million. Loss for the period INR 329 Million. CHENNAI, India, Jan. 12, 2026 (GLOBE NEWSWIRE) — DETAILS OF EARNING CALL January 13, 2026 | 8:30 AM ET | 07:00 PM IST Participant Dial

ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM

ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM GlobeNewswire January 12, 2026 HIGHLIGHTS Results from the Phase 2a ACCENT trial in pancreatic cancer have been presented at the specialist conference ASCO Gastrointestinal Cancer Symposium Updated data analysis continues to show that Narmafotinib combination compares favourably with gemcitabine and Abraxane combination alone Melbourne, Australia, Jan.

Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metastatic Pancreatic Cancer in Oral Presentation at ASCO GI 2026

Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metastatic Pancreatic Cancer in Oral Presentation at ASCO GI 2026 GlobeNewswire January 12, 2026 Phase 2 study met its primary endpoint, demonstrating statistically significant improved overall survival with elraglusib plus gemcitabine/nab-paclitaxel

Defense Spending Is Accelerating the Commercialization of Quantum Computing

Defense Spending Is Accelerating the Commercialization of Quantum Computing Defense Adoption Accelerates as Global Quantum Computing Revenues Are Poised to Reach $2 Billion in 2026 GlobeNewswire January 12, 2026 NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — Market News Updates News Commentary – Quantum computing is moving from the lab into real-world military use, and

Vortex Doors Expands into Minneapolis, Minnesota – Now Offering Expert Door Repair and Maintenance Services

MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) — Vortex Doors, a nationwide leader in commercial and industrial door solutions, is proud to announce the grand opening of its new Minneapolis service center. This expansion brings fast, reliable, and professional door repair, maintenance, and replacement services to businesses throughout Minneapolis, St. Paul, and the greater Twin Cities

Vortex Doors Expands into Minneapolis, Minnesota – Now Offering Expert Door Repair and Maintenance Services

Vortex Doors Expands into Minneapolis, Minnesota – Now Offering Expert Door Repair and Maintenance Services GlobeNewswire January 12, 2026 MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) — Vortex Doors, a nationwide leader in commercial and industrial door solutions, is proud to announce the grand opening of its new Minneapolis service center. This expansion brings fast, reliable,

AITX Announces Measurable and Disciplined Operating Expense Reductions

(Other OTC:AITX),(OTC US:AITX), Focused Actions Reflect Sharpened Execution in Preparation of Next Fiscal Year Detroit, Michigan, Jan. 12, 2026 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, today announced that the Company has implemented measurable and disciplined operating expense reductions year over year,

AITX Announces Measurable and Disciplined Operating Expense Reductions

AITX Announces Measurable and Disciplined Operating Expense Reductions GlobeNewswire January 12, 2026 Focused Actions Reflect Sharpened Execution in Preparation of Next Fiscal Year Detroit, Michigan, Jan. 12, 2026 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, today announced that the Company has implemented

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

(NasdaqGM:CRSP), -2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY(R) launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading gene-editing and siRNA platforms across cardiovascular, autoimmune, oncology and rare diseases- -Starting 2026 with a strong balance sheet with approximately $2 billion in cash, cash equivalents, and marketable securities-

Scroll to Top